Literature DB >> 20616061

c-Ret-mediated hearing loss in mice with Hirschsprung disease.

Nobutaka Ohgami1, Michiru Ida-Eto, Takashi Shimotake, Naomi Sakashita, Michihiko Sone, Tsutomu Nakashima, Keiji Tabuchi, Tomofumi Hoshino, Atsuyoshi Shimada, Toyonori Tsuzuki, Masahiko Yamamoto, Gen Sobue, Mayumi Jijiwa, Naoya Asai, Akira Hara, Masahide Takahashi, Masashi Kato.   

Abstract

A significantly increased risk for dominant sensorineural deafness in patients who have Hirschsprung disease (HSCR) caused by endothelin receptor type B and SOX10 has been reported. Despite the fact that c-RET is the most frequent causal gene of HSCR, it has not been determined whether impairments of c-Ret and c-RET cause congenital deafness in mice and humans. Here, we show that impaired phosphorylation of c-Ret at tyrosine 1062 causes HSCR-linked syndromic congenital deafness in c-Ret knockin (KI) mice. The deafness involves neurodegeneration of spiral ganglion neurons (SGNs) with not only impaired phosphorylation of Akt and NF-kappaB but decreased expression of calbindin D28k in inner ears. The congenital deafness involving neurodegeneration of SGNs in c-Ret KI mice was rescued by introducing constitutively activated RET. Taken together with our results for three patients with congenital deafness with c-RET-mediated severe HSCR, our results indicate that c-Ret and c-RET are a deafness-related molecule in mice and humans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20616061      PMCID: PMC2919946          DOI: 10.1073/pnas.1004520107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Mechanisms of Disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapy.

Authors:  Matthias Drosten; Brigitte M Pützer
Journal:  Nat Clin Pract Oncol       Date:  2006-10

2.  SOX10 mutations in patients with Waardenburg-Hirschsprung disease.

Authors:  V Pingault; N Bondurand; K Kuhlbrodt; D E Goerich; M O Préhu; A Puliti; B Herbarth; I Hermans-Borgmeyer; E Legius; G Matthijs; J Amiel; S Lyonnet; I Ceccherini; G Romeo; J C Smith; A P Read; M Wegner; M Goossens
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

Review 3.  Hirschsprung's disease: genetic and functional associations of Down's and Waardenburg syndromes.

Authors:  S W Moore; A G Johnson
Journal:  Semin Pediatr Surg       Date:  1998-08       Impact factor: 2.754

4.  Roles of disrupted-in-schizophrenia 1-interacting protein girdin in postnatal development of the dentate gyrus.

Authors:  Atsushi Enomoto; Naoya Asai; Takashi Namba; Yun Wang; Takuya Kato; Motoki Tanaka; Hitoshi Tatsumi; Shinichiro Taya; Daisuke Tsuboi; Keisuke Kuroda; Naoko Kaneko; Kazunobu Sawamoto; Rieko Miyamoto; Mayumi Jijiwa; Yoshiki Murakumo; Masahiro Sokabe; Tatsunori Seki; Kozo Kaibuchi; Masahide Takahashi
Journal:  Neuron       Date:  2009-09-24       Impact factor: 17.173

Review 5.  Quiet as a mouse: dissecting the molecular and genetic basis of hearing.

Authors:  Steve D M Brown; Rachel E Hardisty-Hughes; Philomena Mburu
Journal:  Nat Rev Genet       Date:  2008-02-19       Impact factor: 53.242

6.  Calbindin-D28K expression induced by glial cell line-derived neurotrophic factor in substantia nigra neurons dependent on PI3K/Akt/NF-kappaB signaling pathway.

Authors:  Hong-Jun Wang; Jun-Ping Cao; Jing-Kao Yu; Li-Cai Zhang; Zhong-Jian Jiang; Dian-Shuai Gao
Journal:  Eur J Pharmacol       Date:  2008-07-30       Impact factor: 4.432

7.  Effects of delayed treatment with combined GDNF and continuous electrical stimulation on spiral ganglion cell survival in deafened guinea pigs.

Authors:  Verena Scheper; Gerrit Paasche; Josef M Miller; Athanasia Warnecke; Nurdanat Berkingali; Thomas Lenarz; Timo Stöver
Journal:  J Neurosci Res       Date:  2009-05-01       Impact factor: 4.164

8.  Diminished Ret expression compromises neuronal survival in the colon and causes intestinal aganglionosis in mice.

Authors:  Toshihiro Uesaka; Mayumi Nagashimada; Shigenobu Yonemura; Hideki Enomoto
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

9.  Protection against aminoglycoside-induced ototoxicity by regulated AAV vector-mediated GDNF gene transfer into the cochlea.

Authors:  Yuhe Liu; Takashi Okada; Kuniko Shimazaki; Kianoush Sheykholeslami; Tatsuya Nomoto; Shin-Ichi Muramatsu; Hiroaki Mizukami; Akihiro Kume; Shuifang Xiao; Keiichi Ichimura; Keiya Ozawa
Journal:  Mol Ther       Date:  2008-01-08       Impact factor: 11.454

Review 10.  Enteric nervous system development and Hirschsprung's disease: advances in genetic and stem cell studies.

Authors:  Tiffany A Heanue; Vassilis Pachnis
Journal:  Nat Rev Neurosci       Date:  2007-06       Impact factor: 34.870

View more
  23 in total

1.  Correlated expression levels of endothelin receptor B and Plexin C1 in melanoma.

Authors:  Mayuko Y Kumasaka; Ichiro Yajima; Machiko Iida; Hiro Takahashi; Yuji Inoue; Satoshi Fukushima; Hironobu Ihn; Kozue Takeda; Yuji Naito; Toshikazu Yoshikawa; Masashi Kato
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

2.  Manganese-Mediated Decrease in Levels of c-RET and Tyrosine Hydroxylase Expression In Vitro.

Authors:  Mayuko Y Kumasaka; Ichiro Yajima; Nobutaka Ohgami; Hiromasa Ninomiya; Machiko Iida; Xiang Li; Reina Oshino; Hiroko Tanihata; Masafumi Yoshinaga; Masashi Kato
Journal:  Neurotox Res       Date:  2017-07-20       Impact factor: 3.911

3.  An actin-binding protein espin is a growth regulator for melanoma.

Authors:  Takeshi Yanagishita; Ichiro Yajima; Mayuko Kumasaka; Machiko Iida; Li Xiang; Yasuhiko Tamada; Yoshinari Matsumoto; Daisuke Watanabe; Masashi Kato
Journal:  J Invest Dermatol       Date:  2014-06-17       Impact factor: 8.551

Review 4.  c-Ret-mediated hearing losses.

Authors:  Nobutaka Ohgami; Haruka Tamura; Kyoko Ohgami; Machiko Iida; Ichiro Yajima; Mayuko Y Kumasaka; Yuji Goto; Michihiko Sone; Tsutomu Nakashima; Masashi Kato
Journal:  Int J Clin Exp Pathol       Date:  2012-01-01

5.  Partial requirement of endothelin receptor B in spiral ganglion neurons for postnatal development of hearing.

Authors:  Michiru Ida-Eto; Nobutaka Ohgami; Machiko Iida; Ichiro Yajima; Mayuko Y Kumasaka; Kazutaka Takaiwa; Takashi Kimitsuki; Michihiko Sone; Tsutomu Nakashima; Toyonori Tsuzuki; Shizuo Komune; Masashi Yanagisawa; Masashi Kato
Journal:  J Biol Chem       Date:  2011-06-28       Impact factor: 5.157

6.  Reduced GNG2 expression levels in mouse malignant melanomas and human melanoma cell lines.

Authors:  Ichiro Yajima; Mayuko Y Kumasaka; Yuji Naito; Toshikazu Yoshikawa; Hiro Takahashi; Yoko Funasaka; Tamio Suzuki; Masashi Kato
Journal:  Am J Cancer Res       Date:  2012-04-21       Impact factor: 6.166

7.  Characterization of retinal ganglion cell, horizontal cell, and amacrine cell types expressing the neurotrophic receptor tyrosine kinase Ret.

Authors:  Nadia Parmhans; Szilard Sajgo; Jingwen Niu; Wenqin Luo; Tudor Constantin Badea
Journal:  J Comp Neurol       Date:  2017-12-19       Impact factor: 3.215

8.  Glial cell line-derived neurotrophic factor (GDNF) induces neuritogenesis in the cochlear spiral ganglion via neural cell adhesion molecule (NCAM).

Authors:  Sara Euteneuer; Kuo H Yang; Eduardo Chavez; Anke Leichtle; Gabriele Loers; Adel Olshansky; Kwang Pak; Melitta Schachner; Allen F Ryan
Journal:  Mol Cell Neurosci       Date:  2012-12-20       Impact factor: 4.314

9.  GNG2 inhibits invasion of human malignant melanoma cells with decreased FAK activity.

Authors:  Ichiro Yajima; Mayuko Y Kumasaka; Osamu Yamanoshita; Cunchao Zou; Xiang Li; Nobutaka Ohgami; Masashi Kato
Journal:  Am J Cancer Res       Date:  2014-03-01       Impact factor: 6.166

Review 10.  The importance of the RET gene in thyroid cancer and therapeutic implications.

Authors:  Domenico Salvatore; Massimo Santoro; Martin Schlumberger
Journal:  Nat Rev Endocrinol       Date:  2021-02-18       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.